HSE to fund nine delayed medicines

Lessons must be learned from the “dysfunctional” drugs selection process, the Irish Pharmaceutical Healthcare Association has said.

The association, which represents the international research-based pharmaceutical industry in Ireland, welcomed confirmation from the HSE yesterday that it will fund nine delayed medicines.